4//SEC Filing
Wells David R. 4
Accession 0001209191-19-051091
CIK 0001681682other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:16 PM ET
Size
5.3 KB
Accession
0001209191-19-051091
Insider Transaction Report
Form 4
Wells David R.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2019-09-27$1.18/sh+10,000$11,800→ 20,000 total
Holdings
- 24,786(indirect: By StoryCorp Consulting)
Common Stock
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001480371
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:16 PM ET
- Size
- 5.3 KB